Resultados de procura - Olena Barbash
- Mostrando 1 - 19 Resultados de 19
-
1
-
2
Mutations in Fbx4 Inhibit Dimerization of the SCFFbx4 Ligase and Contribute to Cyclin D1 Overexpression in Human Cancer por Olena Barbash, Petia Zamfirova, Douglas I. Lin, Xiangmei Chen, Yang Ke, Hiroshi Nakagawa, Fengmin Lu, Anil K. Rustgi, J. Alan Diehl
Publicado 2008Artigo -
3
The Fbx4 Tumor Suppressor Regulates Cyclin D1 Accumulation and Prevents Neoplastic Transformation por Laura Pontano Vaites, Eric K. Lee, Zhaorui Lian, Olena Barbash, Darshan Roy, Mariusz A. Wasik, Andres J. Klein‐Szanto, Anil K. Rustgi, J. Alan Diehl
Publicado 2011Artigo -
4
Phosphorylation-Dependent Ubiquitination of Cyclin D1 by the SCFFBX4-αB Crystallin Complex por Douglas I. Lin, Olena Barbash, Suresh Kumar, Jason D. Weber, J. Wade Harper, Andres J. Klein–Szanto, Anil K. Rustgi, Serge Y. Fuchs, J. Alan Diehl
Publicado 2006Artigo -
5
“Z4” Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism por Hitoshi Shiota, Janine E. Elya, Artyom A. Alekseyenko, Pauline M. Chou, Shelby Gorman, Olena Barbash, Kelly Becht, Kristina Danga, Mitzi I. Kuroda, Valentina Nardi, Christopher A. French
Publicado 2018Artigo -
6
Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer por Anastasia Wyce, Yan Degenhardt, Yuchen Bai, BaoChau Le, Susan Korenchuk, Ming-Chih Crouthamel, Charles F. McHugh, Robert L. Vessella, Caretha L. Creasy, Peter J. Tummino, Olena Barbash
Publicado 2013Artigo -
7
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms por Justin M. Watts, Mark D. Minden, Kimo Bachiashvili, Andrew M. Brunner, Sameem Abedin, Timothy Crossman, Magdalena Zając, V. V. Moroz, Jacqueline L. Egger, Aarti Tarkar, Brandon E. Kremer, Olena Barbash, Gautam Borthakur
Publicado 2024Artigo -
8
PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression por Kelly Chiang, Agnieszka Zielińska, Abeer M. Shaaban, María Pilar Sánchez-Bailón, James Jarrold, Thomas L. Clarke, Jingxian Zhang, Adele Francis, J. Louise Jones, Sally Smith, Olena Barbash, Ernesto Guccione, Gillian Farnie, Matthew J. Smalley, Clare C. Davies
Publicado 2017Artigo -
9
Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation por Glenn S. Van Aller, Nicolas Reynoird, Olena Barbash, Michael J. Huddleston, Shichong Liu, Anne‐Flore Zmoos, Patrick McDevitt, Robert H. Sinnamon, BaoChau Le, Glòria Mas Martín, Roland S. Annan, Julien Sage, Benjamin A. Garcia, Peter J. Tummino, Or Gozani, Ryan G. Kruger
Publicado 2012Artigo -
10
SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer por Paweł K. Mazur, Nicolas Reynoird, Purvesh Khatri, Pascal W.T.C. Jansen, Alex W. Wilkinson, Shichong Liu, Olena Barbash, Glenn S. Van Aller, Michael J. Huddleston, Dashyant Dhanak, Peter J. Tummino, Ryan G. Kruger, Benjamin A. Garcia, Atul J. Butte, Michiel Vermeulen, Julien Sage, Or Gozani
Publicado 2014Artigo -
11
Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing por Sarah V. Gerhart, Wendy A. Kellner, Christine Thompson, Melissa B. Pappalardi, Xiping Zhang, Rocío Montes de, Elayne Penebre, Kenneth W. Duncan, Ann Boriack-Sjodin, BaoChau Le, Christina R. Majer, Michael T. McCabe, Chris Carpenter, Neil Johnson, Ryan G. Kruger, Olena Barbash
Publicado 2018Artigo -
12
Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses por Andrew Fedoriw, Leilei Shi, Shane W. O’Brien, Kimberly N. Smitheman, Yunfei Wang, Jiakai Hou, Christian Sherk, Satyajit Rajapurkar, Jenny Laraio, Leila J. Williams, Chunyu Xu, Guangchun Han, Qin Feng, Mark T. Bedford, Linghua Wang, Olena Barbash, Ryan G. Kruger, Patrick Hwu, Helai P. Mohammad, Weiyi Peng
Publicado 2022Artigo -
13
BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models por Anastasia Wyce, Gopinath Ganji, Kimberly N. Smitheman, Chun‐wa Chung, Susan Korenchuk, Yuchen Bai, Olena Barbash, BaoChau Le, Peter D. Craggs, Michael T. McCabe, Karen M. Kennedy-Wilson, Lydia V. Sanchez, Romain Gosmini, Nigel J. Parr, Charles F. McHugh, Dashyant Dhanak, Rab K. Prinjha, Kurt R. Auger, Peter J. Tummino
Publicado 2013Artigo -
14
Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762 por Aristeidis Chaidos, Valentina S. Caputo, Katerina Gouvedenou, Binbin Liu, Ilaria Marigo, Mohammed S. Chaudhry, Antonia Rotolo, David F. Tough, Nicholas Smithers, Anna K. Bassil, Trevor Chapman, Nicola Harker, Olena Barbash, Peter J. Tummino, Niam Al-Mahdi, Andrea Haynes, Leanne Cutler, BaoChau Le, Amin Rahemtulla, Irene Roberts, Maurits F. Kleijnen, Jason Witherington, Nigel J. Parr, Rab K. Prinjha, Anastasios Karadimitris
Publicado 2013Artigo -
15
Homologous Recombination Deficiency: Concepts, Definitions, and Assays por Mark Stewart, Diana Merino Vega, Rebecca C. Arend, Jonathan Baden, Olena Barbash, Nike Beaubier, Grace Collins, Tim French, Negar Ghahramani, Patsy Hinson, Petar Jelinic, Matthew J. Marton, Kimberly McGregor, Jerod Parsons, Lakshman Ramamurthy, Mark Sausen, Ethan S. Sokol, Albrecht Stenzinger, Hillary Stires, Kirsten M. Timms, Diana Turco, Iris Wang, J Andrew Williams, Elaine Wong-Ho, Jeff Allen
Publicado 2022Artigo -
16
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors por Sarina A. Piha‐Paul, Christine L. Hann, Christopher A. French, Sophie Cousin, Irene Braña, Phillippe Cassier, Víctor Moreno, Johann S. de Bono, Sara Harward, Geraldine Ferron‐Brady, Olena Barbash, Anastasia Wyce, Yuehui Wu, Thierry Horner, Meg Annan, Nigel J. Parr, Rabinder Prinjha, Christopher L. Carpenter, John Hilton, David S. Hong, Naomi B. Haas, Mark C. Markowski, Arindam Dhar, Peter J. O’Dwyer, Geoffrey I. Shapiro
Publicado 2019Artigo -
17
Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation por Jia Yi Fong, Luca Pignata, Pierre-Alexis Goy, Kimihito C. Kawabata, Stanley Chun-Wei Lee, Cheryl M. Koh, Daniele Musiani, Enrico Massignani, Andriana G. Kotini, Alex Penson, Cheng Mun Wun, Yudao Shen, Megan Schwarz, Diana Low, Alexander Rialdi, Michelle Ki, Heike Wollmann, Slim Mzoughi, Florence Gay, Christine Thompson, Timothy K. Hart, Olena Barbash, Genna M. Luciani, Magdalena M. Szewczyk, Bas J. Wouters, Ruud Delwel, Eirini P. Papapetrou, Dalia Baršytė-Lovejoy, C.H. Arrowsmith, Mark D. Minden, Jian Jin, Ari Melnick, Tiziana Bonaldi, Omar Abdel‐Wahab, Ernesto Guccione
Publicado 2019Artigo -
18
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia por Charles C. Bell, Katie Fennell, Yih-Chih Chan, Florian Rambow, Miriam M. Yeung, Dane Vassiliadis, Luis E. Lara Gonzalez, Paul Yeh, Luciano G. Martelotto, Aljosja Rogiers, Brandon E. Kremer, Olena Barbash, Helai P. Mohammad, Timothy M. Johanson, Marian L. Burr, Arindam Dhar, Natalie O. Karpinich, Luyi Tian, Dean Tyler, Laura MacPherson, Junwei Shi, Nathan Pinnawala, Chun Yew Fong, Anthony T. Papenfuss, Sean M. Grimmond, Sarah‐Jane Dawson, Rhys S. Allan, Ryan G. Kruger, Christopher R. Vakoc, David L. Goode, Shalin H. Naik, Omer Gilan, Enid Y.N. Lam, Jean‐Christophe Marine, Rab K. Prinjha, Mark A. Dawson
Publicado 2019Artigo -
19
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss por Andrew Fedoriw, Satyajit Rajapurkar, Shane W. O’Brien, Sarah V. Gerhart, Lorna H. Mitchell, Nicholas D. Adams, Nathalie Rioux, Trupti Lingaraj, Scott Ribich, Melissa B. Pappalardi, Niyant Shah, Jenny Laraio, Yan Liu, Michael Butticello, Chris Carpenter, Caretha L. Creasy, Susan Korenchuk, Michael T. McCabe, Charles F. McHugh, Raman P. Nagarajan, Craig D. Wagner, Francesca Zappacosta, Roland S. Annan, N.O. Concha, Roberta Thomas, Timothy K. Hart, J. Joshua Smith, Robert A. Copeland, Mikel P. Moyer, John Campbell, Kim Stickland, James E. Mills, Suzanne Jacques-O’Hagan, Christina J. Allain, Danielle Johnston, Alejandra Raimondi, Margaret Porter Scott, Nigel J. Waters, Kerren K. Swinger, Ann Boriack-Sjodin, Thomas V. Riera, Gideon Shapiro, Richard Chesworth, Rabinder Prinjha, Ryan G. Kruger, Olena Barbash, Helai P. Mohammad
Publicado 2019Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Cancer research
Gene
Genetics
Cell biology
Cancer
Biochemistry
Cell cycle
Methylation
Epigenetics
Medicine
Methyltransferase
Molecular biology
Bromodomain
Chemistry
Computational biology
Cyclin A
Cyclin A2
Cyclin D
Cyclin D1
Histone
Carcinogenesis
Cell
Cyclin
Cyclin B
DNA
Gene expression
Internal medicine
Protein arginine methyltransferase 5
Ubiquitin